Tender For Re E-Tender For Procurement Of Drug Items Under Table-A, For Two Years From The Date Of Aoc.

Sharing tender

Tender for Re E-Tender For Procurement Of Drug Items Under Table-A, For Two Years From The Date Of Aoc. , Azacitidine Inj 100 Mg /Vial , Bimatoprost Eye Drop 0.03% , Cabergoline Tab 0.5Mg , Carmustine Inj. 100Mg/Vial , Cefotaxime Sodium Inj. I.P. 125 Mg.Vial. , Cetuximab Inj. 100Mg( 5Mg/Ml) / - 20Ml Vial , Cetuximab Inj. 500 Mg (5Mg/Ml)/100Ml Vial , Chloramphenicol-5% W/V + Betamethasone Valerate- 0.1% W/V + Lidocaine-2% W/V Ear Drop - 5Ml , Comb. Gastric Antacid Susp. (Al.+ Mg. Hydroxide) (Total Salt Being Not Less Than 500Mg/5Ml.) , Daclatasvir 60 Mg Tab. , Decitabine Inj 50 Mg , Desflurane Inhalation Agent 240 Ml [Note: Vaporizer To Be Installed By The Manufacturer At Free Of Costs At Hospitals Where Needed For Use Of Desflurane] , Dexamethasone Tab. I.P. 0.5 Mg , Digoxin Tablet I.P. 0.25 Mg , Dorzolamide Hydrochloride 2.0% Eye Drop In 5Ml , Fibrin Sealent With Fast & Slow Setting Of Thrombin 1Ml , Fludarabine Inj. - 50Mg / 5Ml , Flurourocil Inj. I.P. 250Mg. In 5Ml. Amp. , Fluticasone Nasal Spray Ip 50 Mcg (In Maximum Of 120 Mdi Pack) , Halazone Tablet For Solution U.S.P. 4Mg , Human Hepatitis B Immunoglobulin Inj. 200 Iu Volume In 0.5 Ml Or 1 Ml Vial/Pfs , Ibrutinib 140 Mg Cap. , Infliximab Inj. 100Mg/Vial , Isosorbide-5-Mononitrate 20 Mg , Isosorbide-Dinitrate Tab I.P. 5Mg. , Ivermectin 6Mg Tab. , Leuprolide Depot Inj. 22.5 Mg/Vial , Levosalbutamol 1.25 Mg + Ipratropium Bromide 500Mcg Respules , Levosalbutamol Oral Suspension 1Mg/5Ml , Linezolid Syrup 100Mg / 5Ml , Melphalan Hcl Inj. 50 Mg (Powder) , Methotrexate Tab 15 Mg , Neostigmine Methylsulphate Inj.I.P. 0.5Mg/ Ml - 1Ml Ampoule , Penicillamine 250 Mg. Cap. , Plasma Derived Factor Ix In Vial , Plerixafor Inj 24Mg/1.2Ml Per Vial , Pomalidomide 2Mg Tab / Cap , Prednisolone Tab.20Mg. , Pyrazinamide Tab. I.P. 500Mg , Pyridostigmine Tab 30 Mg , Sodium Fusidate Cream / Ointment 2% , Succinylated Polygelline , Sulphamethoxazole 200 Mg + Trimethoprim 40 Mg /5Ml Oral Suspension , Tetanus Toxoid Inj. (Absorbed) 0.5Ml Amp. Single Dose , Tinidazole Tab Ip 500 Mg , Tropicamide 0.8% With Phenylephrine Hydrochloride 5% Eye Drop , Valethamate Bromide Inj 8 Mg/Ml In 1Ml Amp. , Vecuronium Bromide Inj. 2Mg /Ml 2Ml Vial , Important Note: 1. All Prospective Bidders Are Requested To Quote The Rate In Boq As Per Accounting Unit & Item Specification As Mentioned In The Table-A. Wrong Quoting Of The Rate In Boq Will Be Dealt With As Per Penal Provisions Of The T&C Of The Tender. 2. Tendered Quantity Is Just A Tentative Quantity And Should Not Be Treated As Final. It May Increase Or Decrease, As Per Need Of The State. Keeping This In Mind, The Supplier Is Not Allowed To Seek Termination Of The Rate Contract After Finishing Supply Of Tendered Quantity. 3. Quality Of The Product Supplied, May Be Ascertained By Testing / Physical Examination By The Experts At Any Stage Of The Tender Period. 4. The Prospective Bidders Of The Said Tender Are Requested To Make A Declaration In Affidavit Under Annexure Vi(B) In Case Of Sole Manufacturer/Importer (I.E. Proprietary In Nature). 5. If The Item(S) Under Sole Manufacturer / Importer Is (Are) Proprietary In Nature, Quarterly Intimation Is Solicited From The Approved Bidders Positively Regarding The Status Of Their Item(S) Proprietary In Nature, Otherwise Their Item(S) Will Be Blocked In The Smis. 6. In Case Of Tie Bid, Decision Will Be Taken By The Tia As Per G.O. No. 2320-F(Y), Dated 07.06.2022 Issued From Finance Department Audit Branch (Group T).